Cargando…
Correction: A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in Rabbits
Autores principales: | Brignole-Baudouin, Françoise, Desbenoit, Nicolas, Hamm, Gregory, Liang, Hong, Both, Jean-Pierre, Brunelle, Alain, Fournier, Isabelle, Guerineau, Vincent, Legouffe, Raphael, Stauber, Jonathan, Touboul, David, Wisztorski, Maxence, Salzet, Michel, Laprevote, Olivier, Baudouin, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608857/ http://dx.doi.org/10.1371/annotation/b97d3c0d-b49e-40e3-a6b4-5155bd9bf3c9 |
Ejemplares similares
-
A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in Rabbits
por: Brignole-Baudouin, Françoise, et al.
Publicado: (2012) -
Effects of Benzalkonium Chloride on THP-1 Differentiated Macrophages In Vitro
por: Michée, Sylvain, et al.
Publicado: (2013) -
Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro
por: Clouzeau, Chloé, et al.
Publicado: (2012) -
The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
por: Datta, Sandipan, et al.
Publicado: (2017) -
Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride
por: Liang, H, et al.
Publicado: (2008)